Sr One Capital Management

Latest statistics and disclosures from Sr One Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ACLX, CRSP, SPRY, NKTX, DSGN, and represent 92.85% of Sr One Capital Management's stock portfolio.
  • Added to shares of these 3 stocks: CRSP (+$72M), NKTX (+$22M), MLYS.
  • Started 1 new stock position in CRSP.
  • Reduced shares in these 1 stock: ACLX (-$56M).
  • Sr One Capital Management was a net buyer of stock by $40M.
  • Sr One Capital Management has $364M in assets under management (AUM), dropping by 52.88%.
  • Central Index Key (CIK): 0001910264

Tip: Access up to 7 years of quarterly data

Positions held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Sr One Capital Management

Sr One Capital Management holds 6 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arcellx Common Stock (ACLX) 44.8 $163M -25% 2.3M 69.55
 View chart
Crispr Therapeutics Namen Akt (CRSP) 19.6 $72M NEW 1.0M 68.16
 View chart
Silverback Therapeutics (SPRY) 11.3 $41M 4.0M 10.22
 View chart
Nkarta (NKTX) 9.9 $36M +150% 3.3M 10.81
 View chart
Design Therapeutics (DSGN) 7.2 $26M 6.5M 4.03
 View chart
Mineralys Therapeutics (MLYS) 7.2 $26M +12% 2.0M 12.91
 View chart

Past Filings by Sr One Capital Management

SEC 13F filings are viewable for Sr One Capital Management going back to 2021